Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Biomed Inform ; 85: 149-154, 2018 09.
Article in English | MEDLINE | ID: mdl-30081101

ABSTRACT

The synergistic effect of drug combination is one of the most desirable properties for treating cancer. However, systematically predicting effective drug combination is a significant challenge. We report here a novel method based on deep belief network to predict drug synergy from gene expression, pathway and the Ontology Fingerprints-a literature derived ontological profile of genes. Using data sets provided by 2015 DREAM competition, our analysis shows that this integrative method outperforms published results from the DREAM website for 4999 drug pairs, demonstrating the feasibility of predicting drug synergy from literature and the -omics data using advanced artificial intelligence approach.


Subject(s)
Deep Learning , Drug Combinations , Drug Synergism , Antineoplastic Combined Chemotherapy Protocols , Cell Line, Tumor , Computational Biology , Databases, Pharmaceutical , Gene Expression Profiling , Gene Ontology , Gene Regulatory Networks , Humans , Neoplasms/drug therapy , Neoplasms/genetics
2.
Genome Med ; 9(1): 24, 2017 03 09.
Article in English | MEDLINE | ID: mdl-28279190

ABSTRACT

BACKGROUND: Imiquimod (IMQ) produces a cutaneous phenotype in mice frequently studied as an acute model of human psoriasis. Whether this phenotype depends on strain or sex has never been systematically investigated on a large scale. Such effects, however, could lead to conflicts among studies, while further impacting study outcomes and efforts to translate research findings. METHODS: RNA-seq was used to evaluate the psoriasiform phenotype elicited by 6 days of Aldara (5% IMQ) treatment in both sexes of seven mouse strains (C57BL/6 J (B6), BALB/cJ, CD1, DBA/1 J, FVB/NJ, 129X1/SvJ, and MOLF/EiJ). RESULTS: In most strains, IMQ altered gene expression in a manner consistent with human psoriasis, partly due to innate immune activation and decreased homeostatic gene expression. The response of MOLF males was aberrant, however, with decreased expression of differentiation-associated genes (elevated in other strains). Key aspects of the IMQ response differed between the two most commonly studied strains (BALB/c and B6). Compared with BALB/c, the B6 phenotype showed increased expression of genes associated with DNA replication, IL-17A stimulation, and activated CD8+ T cells, but decreased expression of genes associated with interferon signaling and CD4+ T cells. Although IMQ-induced expression shifts mirrored psoriasis, responses in BALB/c, 129/SvJ, DBA, and MOLF mice were more consistent with other human skin conditions (e.g., wounds or infections). IMQ responses in B6 mice were most consistent with human psoriasis and best replicated expression patterns specific to psoriasis lesions. CONCLUSIONS: These findings demonstrate strain-dependent aspects of IMQ dermatitis in mice. We have shown that IMQ does not uniquely model psoriasis but in fact triggers a core set of pathways active in diverse skin diseases. Nonetheless, our findings suggest that B6 mice provide a better background than other strains for modeling psoriasis disease mechanisms.


Subject(s)
Aminoquinolines/pharmacology , Disease Models, Animal , Gene Expression Regulation , Mice, Inbred Strains , Psoriasis/genetics , Skin/drug effects , Animals , Female , Humans , Imiquimod , Interleukin-17/genetics , Male , Mice , Psoriasis/metabolism , Sequence Analysis, RNA , Sex Factors , Skin/metabolism , Species Specificity
3.
Arthritis Rheumatol ; 69(5): 1054-1066, 2017 05.
Article in English | MEDLINE | ID: mdl-28029757

ABSTRACT

OBJECTIVE: To identify risk alleles relevant to the causal and biologic mechanisms of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). METHODS: A genome-wide association study and subsequent replication study were conducted in a total cohort of 1,986 cases of AAV (patients with granulomatosis with polyangiitis [Wegener's] [GPA] or microscopic polyangiitis [MPA]) and 4,723 healthy controls. Meta-analysis of these data sets and functional annotation of identified risk loci were performed, and candidate disease variants with unknown functional effects were investigated for their impact on gene expression and/or protein function. RESULTS: Among the genome-wide significant associations identified, the largest effect on risk of AAV came from the single-nucleotide polymorphism variants rs141530233 and rs1042169 at the HLA-DPB1 locus (odds ratio [OR] 2.99 and OR 2.82, respectively) which, together with a third variant, rs386699872, constitute a triallelic risk haplotype associated with reduced expression of the HLA-DPB1 gene and HLA-DP protein in B cells and monocytes and with increased frequency of complementary proteinase 3 (PR3)-reactive T cells relative to that in carriers of the protective haplotype. Significant associations were also observed at the SERPINA1 and PTPN22 loci, the peak signals arising from functionally relevant missense variants, and at PRTN3, in which the top-scoring variant correlated with increased PRTN3 expression in neutrophils. Effects of individual loci on AAV risk differed between patients with GPA and those with MPA or between patients with PR3-ANCAs and those with myeloperoxidase-ANCAs, but the collective population attributable fraction for these variants was substantive, at 77%. CONCLUSION: This study reveals the association of susceptibility to GPA and MPA with functional gene variants that explain much of the genetic etiology of AAV, could influence and possibly be predictors of the clinical presentation, and appear to alter immune cell proteins and responses likely to be key factors in the pathogenesis of AAV.


Subject(s)
Granulomatosis with Polyangiitis/genetics , HLA-DP beta-Chains/genetics , Microscopic Polyangiitis/genetics , Myeloblastin/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 22/genetics , T-Lymphocytes/metabolism , alpha 1-Antitrypsin/genetics , Adult , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/genetics , Autoantigens/immunology , B-Lymphocytes/metabolism , Case-Control Studies , Female , Gene Expression , Genetic Predisposition to Disease , Genome-Wide Association Study , HLA-DP Antigens/metabolism , HLA-DP beta-Chains/metabolism , Haplotypes , Humans , Male , Middle Aged , Monocytes/metabolism , Myeloblastin/immunology , Neutrophils/metabolism , Odds Ratio , Peroxidase/immunology , Polymorphism, Single Nucleotide , T-Lymphocytes/immunology
4.
J Pept Sci ; 12(9): 605-11, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16733830

ABSTRACT

Serine protease inhibitors are widely distributed in the plant kingdom. Many of them have been purified and characterized from different species. While the physicochemical properties of these protease inhibitors have been extensively investigated, their biological effects, e.g. immunomodulatory effect, remain relatively unexplored. Recently, we isolated a chymotrypsin-specific inhibitor (MCoCI) from the seeds of Momordica cochinchinensis (Lour) Spreng (Family Cucurbitaceae), the traditional Chinese medicine known as Mubiezhi, which has been used as an antiinflammatory agent. In the present study, the effects of MCoCI on different types of cells of the immune system, including splenocytes, splenic lymphocytes, neutrophils, bone marrow cells and macrophages, were investigated. MCoCI was shown to possess immuno-enhancing and antiinflammatory effects. MCoCI could stimulate the proliferation of different cells of the immune system, e.g. splenocytes, splenic lymphocytes and bone marrow cells, in a manner comparable to that of Concanavalin A. Moreover, MCoCI could also suppress the formation of hydrogen peroxide in neutrophils and macrophages. These immunomodulatory effects may explain some of the therapeutic actions of Mubiezhi.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Chymotrypsin/antagonists & inhibitors , Immunologic Factors/pharmacology , Plant Proteins/pharmacology , Serine Proteinase Inhibitors/pharmacology , Animals , Bone Marrow Cells/drug effects , Bone Marrow Cells/immunology , Dose-Response Relationship, Drug , Lymphocytes/drug effects , Lymphocytes/immunology , Macrophages/drug effects , Macrophages/immunology , Mice , Mice, Inbred BALB C , Momordica/chemistry , Momordica/enzymology , Seeds/chemistry , Seeds/enzymology , Spleen/drug effects , Spleen/immunology
5.
J Pept Sci ; 11(10): 665-8, 2005 Oct.
Article in English | MEDLINE | ID: mdl-15849778

ABSTRACT

The antioxidative activity of a chymotrypsin-specific potato type I inhibitor from Momordica cochinchinensis (MCoCI) (Cucurbitaceae) has been investigated using the primary rat hepatocyte system. tert-Butyl hydroperoxide (t-BHP) was used to induce oxidative stress. Pretreatment of hepatocytes with MCoCI for 24 h significantly reversed t-BHP-induced cell damage, and the associated glutathione depletion and lipid peroxidation. The activities of glutathione-S-transferase and superoxide dismutase were also increased. These results suggested that MCoCI possessed antioxidative activity which may account for some of the pharmacological effects of Momordica cochinchinensis seeds, the traditional Chinese medicine known as Mubiezhi, from which MCoCI was isolated.


Subject(s)
Antioxidants/pharmacology , Chymotrypsin/antagonists & inhibitors , Hepatocytes/drug effects , Serine Proteinase Inhibitors/pharmacology , Animals , Catalase/metabolism , Cells, Cultured , Glutathione Reductase/metabolism , Glutathione Transferase/metabolism , Lipid Peroxidation/drug effects , Momordica/chemistry , Rats , Seeds/chemistry , Superoxide Dismutase/metabolism , tert-Butylhydroperoxide/antagonists & inhibitors , tert-Butylhydroperoxide/pharmacology
6.
Biol Chem ; 385(2): 185-9, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15101561

ABSTRACT

A 7514-Da chymotrypsin inhibitor was isolated from the seed extract of Momordica cochinchinensis (Family Cucurbitaceae) by chromatography on chymotrypsin-Sepharose 4B and subsequently by C18 reversed-phase HPLC. This inhibitor, named MCoCl, possessed remarkable thermostability and was stable from pH 2 to 12. MCoCl also inhibited subtilisin, but had at least 50-fold lower inhibitory activity towards trypsin and elastase. Amino acid sequencing of a peptide fragment of MCoCl revealed a sequence of 23 amino acids. Comparison of this sequence and the molecular mass with those of other protease inhibitors suggests that MCoCl belongs to the potato I inhibitor family.


Subject(s)
Chymotrypsin/antagonists & inhibitors , Momordica/enzymology , Seeds/enzymology , Serine Proteinase Inhibitors/chemistry , Serine Proteinase Inhibitors/pharmacology , Amino Acid Sequence , Chromatography, Affinity , Chromatography, High Pressure Liquid/methods , Molecular Sequence Data , Molecular Weight , Pancreatic Elastase/antagonists & inhibitors , Peptide Fragments/genetics , Sequence Alignment , Serine Proteinase Inhibitors/genetics , Serine Proteinase Inhibitors/isolation & purification , Solanum tuberosum/enzymology , Subtilisins/antagonists & inhibitors , Trypsin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...